Latest


Cadila Healthcare gets USFDA nod for metronidazole tablets

  •   Mon, Nov 21 2016 02:42:06 PM

Chennai, Nov 21 (IANS): Pharma major Cadila Healthcare Ltd. on Monday said it has received the final approval from the US Food and Drug Administration (USFDA) to market metronidazole tablets.

In a regulatory filing with BSE, Cadila Healthcare said it has got USFDA's approval to market metronidazole in strengths 250 mg and 500 mg tablets.

The drug is used to treat infections caused by bacteria or parasites.

According to Cadila Healthcare, the tablets will be made at the group's formulations manufacturing facility at Baddi in Himachal Pradesh.

The company said the group now has more than 105 approvals and has so far filed nearly 275 ANDAs (Abbreviated New Drug Application) since the commencement of the filing process in FY 2003-04.
  

Top Stories

Mangaluru: Divine Motors launches Infinity Bounce scooter in grand event

  •   4 hours ago    10

Leave a Comment

Title: Cadila Healthcare gets USFDA nod for metronidazole tablets



You have 2000 characters left.

Disclaimer:

Please write your correct name and email address. Kindly do not post any personal, abusive, defamatory, infringing, obscene, indecent, discriminatory or unlawful or similar comments. Daijiworld.com will not be responsible for any defamatory message posted under this article.

Please note that sending false messages to insult, defame, intimidate, mislead or deceive people or to intentionally cause public disorder is punishable under law. It is obligatory on Daijiworld to provide the IP address and other details of senders of such comments, to the authority concerned upon request.

Hence, sending offensive comments using daijiworld will be purely at your own risk, and in no way will Daijiworld.com be held responsible.

You might also like